Open Medicine Foundation (OMF)

Open Medicine Foundation (OMF)

@openmedf.bsky.social

OMF is fundraising to support open, collaborative research to find effective treatments and a cure for ME/CFS, Long COVID, and related diseases.

4.4K followers668 following785 posts

OMF Founder & CEO Linda Tannenbaum visited OMF’s ME/CFS Collaborative Research Center at Montreal earlier this month. Each member presented their work. “They are excited about their own research,” Linda said. That energy fuels everything we do. 💙

Open Medicine Foundation (OMF) reposted

A treatment's mechanism of action is the specific biological process by which it produces its effect in the body. Understanding mechanism of action helps clinicians make smarter, more personalized treatment choices for people living with ME/CFS & Long COVID.

Open Medicine Foundation (OMF) reposted

In this OMF Journal Club, Dr. Danielle Meadows walks through "Facility-Measured Sleep Electroencephalographic Microstructures in Long COVID" (Sun et al., 2026), a paper from Dr. Janet Mullington's team in collaboration with OMF's Computational Research Center for Complex Diseases.

Multi-omics is a style of research that combines multiple layers of biological data—including genomics (genes), proteomics (proteins), and metabolomics (metabolites)---to build a complete picture of what is happening inside the body.

View full thread

Multi-omics is a style of research that combines multiple layers of biological data—including genomics (genes), proteomics (proteins), and metabolomics (metabolites)---to build a complete picture of what is happening inside the body.

Instead of studying one biological system at a time, multi-omics looks at many systems simultaneously to identify patterns. As a multi-system chronic complex disease, multi-omics is incredibly valuable in ME/CFS research.

Nearly 1,700 of you completed our deep dive survey on post-exertional symptom worsening. In the survey we presented two frameworks: a staged model of post-exertional worsening, and a proposed set of outcome measures for decentralized treatment trials.

View full thread

These survey results go directly into CTN Lite trial design, and we continue to learn from patterns in your responses. They shape the outcome measures we select, the way we define and track PEM, and how we build trial protocols that can accommodate patients across the full severity spectrum.

Nearly 1,700 of you completed our deep dive survey on post-exertional symptom worsening. In the survey we presented two frameworks: a staged model of post-exertional worsening, and a proposed set of outcome measures for decentralized treatment trials.

A DSMB is an independent group of medical and scientific experts who watch over a clinical trial while it's happening. They regularly review incoming data to make sure participants aren't being harmed and that the study is running fairly and ethically.

In ME/CFS clinical trials, a DSMB can be a critical safeguard for participants’ wellbeing, particularly in studies that are investigating drugs that haven’t been used frequently or at all in the disease. It can also add a layer of scientific credibility to trials.

Gut dysbiosis is an imbalance in the microorganisms—bacteria, fungi, and viruses—that live in your digestive system. When this “community” is disrupted, it can interfere with digestion, immune function, and even how your brain and body communicate.

View full thread

OMF’s Melbourne ME/CFS Collaboration has explored the relationship between ME/CFS and gut dysbiosis by studying the impact that a common comorbidity, irritable bowel syndrome, has on metabolite signatures of the disease. 🔗 Read more about the project: ow.ly/58j350ZO1TM

ow.lyMetabolic Differentiation of ME/CFS and its Comorbidities - Open Medicine FoundationTo investigate the metabolite signatures of ME/CFS patient stool, urine, and blood samples and the impact that co-morbidities have on these signatures.

Gut dysbiosis is an imbalance in the microorganisms—bacteria, fungi, and viruses—that live in your digestive system. When this “community” is disrupted, it can interfere with digestion, immune function, and even how your brain and body communicate.

Traditional clinical studies require participants to travel to a single site, which is a barrier that leaves many people unable to take part in research. Decentralized studies offer more flexible options for participating in research like local lab visits, home collection kits, or virtual check-ins.

OMF’s Clinical Trials Network Lite (CTN Lite) initiative will include treatment trials that use decentralized study designs, making the studies more accessible to people with more severe ME/CFS. 🔗Read more about CTN Lite: www.omf.ngo/introducing-...

omf.ngoA new chapter in ME/CFS treatment research begins today—and your voice is essential to making it count. - Open Medicine FoundationLearn more about CTN Lite, a research model designed to accelerate ME/CFS treatment trials and expand access.

Membrane potential is the difference in voltage between the inside and outside of a membrane (e.g., cell membrane). It’s created by concentration gradients of ions, and it powers a cell's essential functions, like producing energy and sending signals.

In #MECFS, there is evidence that cells and mitochondria in patients may struggle to maintain this electrical balance. This can disrupt the body's ability to generate energy and may help explain the profound fatigue that people experience.

OMF’s Collaborative Center at Stanford University is investigating decreased mitochondrial membrane potential through the itaconate shunt hypothesis.    Read more about the study on our website: https:// ow.ly/tmsE50ZHpuI

ow.lyRegulation of the Itaconate Shunt in ME/CFS - Open Medicine FoundationExplore new Stanford Collaboration study aiming to characterize the mitochondrial function in whole peripheral blood mononuclear cells in ME/CFS.

Open Medicine Foundation (OMF) reposted